Thr325Ile polymorphism of the TAFI gene does not influence the risk of myocardial infarction-Reference-Cited by-同舟云学术

Thr325Ile polymorphism of the TAFI gene does not influence the risk of myocardial infarction

Published:2002-03-01 Issue:5 Volume:99 Page:1878-1878
ISSN:1528-0020
Container-title:Blood
language:en
Short-container-title:

Author:

Morange Pierre E.¹,Henry Mireille¹,Frere Corinne¹,Juhan-Vague Irène¹

Affiliation:

1. Correspondence: I. Juhan-Vague, Lab Hematol, CHU Timone, 13385 Marseille cedex 5, France; e-mail:

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/99/5/1878/1681149/h8050201873d.pdf

Reference7 articles.

1. A polymorphism at position −438 in the promoter region of the thrombin-activatable fibrinolysis inhibitor (TAFI) is strongly associated with plasma antigen levels in healthy older men and women [abstract].;Crainich;Circulation.,2000

2. Identification of polymorphisms in the promoter and the 3′ region of the TAFI gene: evidence that plasma TAFI antigen levels are strongly genetically controlled.;Henry;Blood.,2001

3. Identification of polymorphisms in the 5'-untranslated region of the TAFI gene: relationship with plasma TAFI levels and risk of venous thrombosis.;Franco;Haematologica.,2001

4. Identification and characterization of two thrombin-activable fibrinolysis inhibitor isoforms.;Zhao;Thromb Haemost.,1998

5. Combined segregation-linkage analysis of plasma thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels with TAFI gene polymorphisms.;Tregouet;Hum Genet.,2001

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carboxypeptidase U (CPU, TAFIa, CPB2) in Thromboembolic Disease: What Do We Know Three Decades after Its Discovery?;International Journal of Molecular Sciences;2021-01-17

2. Genetic Polymorphisms Associated with Thrombotic Disease Comparison of Two Territories: Myocardial Infarction and Ischemic Stroke;Disease Markers;2019-10-30

3. Effect of single nucleotide polymorphism in thrombin-activatable fibrinolysis inhibitor on the risk of diabetic macrovascular disease;Blood Coagulation & Fibrinolysis;2015-03

4. Genetic variations in the thrombin-activatable fibrinolysis inhibitor gene and risk of cardiovascular disease: A systematic review and meta-analysis;Thrombosis Research;2014-09

5. Procarboxypeptidase U (TAFI) contributes to the risk of thrombosis in patients with hereditary thrombophilia;Thrombosis Research;2009-09